Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers
Anne M Wolka, Angelyn O Fairchild, Shelby D Reed, et al.
Gastroenterology
|
July 14, 2007
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy
F Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Psychiatric Services (Washington, D.C.)
|
March 17, 2015
Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment
Bennett Levitan, Michael Markowitz, Ateesha F Mohamed, et al.
Cancer Medicine
|
July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple Myeloma
Jessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 10, 2006
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment
David Osoba, Ming-Ann Hsu, Catherine Copley-Merriman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 21, 2013
Physician preferences for extra-glycemic effects of type 2 diabetes treatments
Christine Poulos, Juan Marcos González, Lauren J Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 21, 2017
Corrigendum: What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Deborah A Marshall, Juan Marcos Gonzalez, F Reed Johnson, et al.
Circulation. Cardiovascular Interventions
|
November 23, 2019
Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms
Shelby D Reed, Angelyn O Fairchild, F Reed Johnson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 3, 2016
What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Deborah A Marshall, Juan Marcos Gonzalez, F Reed Johnson, et al.
Environmental Health : a Global Access Science Source
|
January 23, 2003
Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution
David M Stieb, Paul De Civita, F Reed Johnson, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers
Anne M Wolka, Angelyn O Fairchild, Shelby D Reed, et al.
Gastroenterology
|
July 14, 2007
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy
F Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Psychiatric Services (Washington, D.C.)
|
March 17, 2015
Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment
Bennett Levitan, Michael Markowitz, Ateesha F Mohamed, et al.
Cancer Medicine
|
July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple Myeloma
Jessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 10, 2006
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment
David Osoba, Ming-Ann Hsu, Catherine Copley-Merriman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 21, 2013
Physician preferences for extra-glycemic effects of type 2 diabetes treatments
Christine Poulos, Juan Marcos González, Lauren J Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 21, 2017
Corrigendum: What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Deborah A Marshall, Juan Marcos Gonzalez, F Reed Johnson, et al.
Circulation. Cardiovascular Interventions
|
November 23, 2019
Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms
Shelby D Reed, Angelyn O Fairchild, F Reed Johnson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 3, 2016
What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Deborah A Marshall, Juan Marcos Gonzalez, F Reed Johnson, et al.
Environmental Health : a Global Access Science Source
|
January 23, 2003
Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution
David M Stieb, Paul De Civita, F Reed Johnson, et al.
Page
of 12